17beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 4885-4892

  Cui, Yu Hong ^a   Tan, Zhi ^a   Fu, Xiao Dong ^a   Xiang, Qiu Ling ^a   Xu, Jin Wen ^a   Wang, Ting Huai ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

17beta estradiol; Cardiomyocytes; Caveolin 3; ERK1 2; Myocardial hypertrophy; Signaling pathway

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; CAVEOLIN 3; ESTRADIOL; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; BETA CYCLODEXTRIN DERIVATIVE; METHYL-BETA-CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CELL SIZE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FEMALE; FRACTIONAL SHORTENING; HEART CELL CULTURE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART WEIGHT; INTERVENTRICULAR SEPTAL THICKNESS AT DIASTOLE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CAVEOLA; DRUG EFFECT; ELECTROCARDIOGRAPHY; ENZYMOLOGY; HEART MUSCLE; HYPERTROPHY; METABOLISM; OVARIECTOMY; PATHOLOGY; PRESSURE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

RATTUS;

ANIMALS; BETA-CYCLODEXTRINS; BLOTTING, WESTERN; CAVEOLAE; CAVEOLIN 3; ELECTROCARDIOGRAPHY; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HYPERTROPHY; MYOCARDIUM; OVARIECTOMY; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84855236757     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0630-0     Document Type: Article

References (40)

1. Zou XJ, Yang L, Yao SL (2008) Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro. Exp Biol Med (Maywood) 233:200-208 (Pubitemid 351231552)
2. Kannel WB (2000) Incidence and epidemiology of heart failure. Heart Fail Rev 5:167-173
3. Lim WK, Wren B, Jepson N, Roy S, Caplan G (1999) Effect of hormone replacement therapy on left ventricular hypertrophy. Am J Cardiol 83:1132-1134, A1139 (Pubitemid 29162806)
4. Maris ME, Melchert RB, Joseph J, Kennedy RH (2005) Gender differences in blood pressure and heart rate in spontaneously hypertensive and Wistar-Kyoto rats. Clin Exp Pharmacol Physiol 32:35-39 (Pubitemid 40314467)
5. Babiker FA, Lips D, Meyer R, Delvaux E, Zandberg P, Janssen B et al (2006) Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vasc Biol 26:1524-1530 (Pubitemid 44288978)
6. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet Jet al(1997) Cell-type and tissue-specific expressionofcaveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272:29337-29346 (Pubitemid 27498228)
7. Thomas CM, Smart EJ (2008) Caveolae structure and function. J Cell Mol Med 12:796-809
8. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M et al (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated gly-coproteins. J Biol Chem 271:15160-15165 (Pubitemid 26197582)
9. Meldrum DR, Wang M, Tsai BM, Kher A, Pitcher JM, Brown JW et al (2005) Intracellular signaling mechanisms of sex hormones in acute myocardial inflammation and injury. Front Biosci 10:1835-1867 (Pubitemid 40529042)
10. Bueno OF, De Windt LJ, Lim HW, Tymitz KM, Witt SA, Kimball TR et al (2001) The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ Res 88:88-96 (Pubitemid 32064088)
11. Kim N, Kim H, Youm JB, Park WS, Warda M, Ko JH et al (2006) Site specific differential activation of ras/raf/ERK signaling in rabbit isoproterenol- induced left ventricular hypertrophy. Biochim Biophys Acta 1763:1067-1075 (Pubitemid 44479795)
12. Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, Gwathmey J et al (2001) Differential activation of signal trans-duction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103:670-677 (Pubitemid 32144195)
13. Fujita T, Toya Y, Iwatsubo K, Onda T, Kimura K, Umemura S et al (2001) Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc Res 51:709-716 (Pubitemid 32800712)
14. Piech A, Massart PE, Dessy C, Feron O, Havaux X, Morel N et al (2002) Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 282:H219-H231 (Pubitemid 34654153)
15. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J et al (2002) Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277:38988-38997 (Pubitemid 35154765)
16. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T et al (1998) Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaf-folding domain. FEBS Lett 428:205-211 (Pubitemid 28319685)
17. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL et al (2003) Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17:1263-1293 (Pubitemid 36857335)
18. JonesNC,Fedorov YV, Rosenthal RS, OlwinBB(2001) ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol 186:104-115
19. Kawabe J, Okumura S, Lee MC, Sadoshima J, Ishikawa Y (2004) Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286:H1845-H1852 (Pubitemid 38525474)
20. Kawamura S, Miyamoto S, Brown JH (2003) Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. J Biol Chem 278:31111-31117 (Pubitemid 36994626)
21. Bellott AC, Patel KC, Burkholder TJ (2005) Reduction of cave-olin-3 expression does not inhibit stretch-induced phosphoryla-tion of ERK2 in skeletal muscle myotubes. J Appl Physiol 98: 1554-1561 (Pubitemid 40396537)
22. Doll D, Sarikas A, Krajcik R, Zolk O (2007) Proteomic expression analysis of cardiomyocytes subjected to proteasome inhibition. Biochem Biophys Res Commun 353:436-442 (Pubitemid 46014582)
23. Patten RD, Aronovitz MJ, Einstein M, Lambert M, Pandian NG, Mendelsohn ME et al (2003) Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse. Clin Sci (Lond) 104:109-118 (Pubitemid 36238043)
24. Sharkey LC, Holycross BJ, Park S, Shiry LJ, Hoepf TM, McCune SA et al (1999) Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF/Mcc-fa cp rats. J Mol Cell Cardiol 31:1527-1537 (Pubitemid 29361119)
25. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA (2001) 17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104:1419-1423 (Pubitemid 32880156)
26. Garrington TP, Johnson GL (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11:211-218 (Pubitemid 29164036)
27. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R et al (2000) The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19:6341-6350
28. Hunter JJ, Tanaka N, Rockman HA, Ross J Jr, Chien KR (1995) Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in trans-genic mice. J Biol Chem 270:23173-23178
29. Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589-600 (Pubitemid 44325350)
30. Horikawa YT, Patel HH, Tsutsumi YM, Jennings MM, Kidd MW, Hagiwara Y et al (2008) Caveolin-3 expression and cave-olae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol 44:123-130
31. Kikuchi T, Oka N, Koga A, Miyazaki H, Ohmura H, Imaizumi T (2005) Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy. J Cardiovasc Pharmacol 45: 204-210 (Pubitemid 40328141)
32. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M et al (2001) Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-gly-coprotein complex, and t-tubule abnormalities. J Biol Chem 276: 21425-21433
33. Galbiati F, Volonte D, Chu JB, Li M, Fine SW, Fu M et al (2000) Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad Sci USA 97:9689-9694 (Pubitemid 30650837)
34. Volonte D, Peoples AJ, Galbiati F (2003) Modulation of myo-blast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C. Mol Biol Cell 14:4075-4088 (Pubitemid 37186310)
35. Galbiati F, Volonte D, Engelman JA, Scherer PE, Lisanti MP (1999) Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem 274:30315-30321
36. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE et al (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19:7289-7304 (Pubitemid 29493393)
37. Liu HM, Zhao XF, Guo LN, Tan Z, Wang TH (2007) Effects of caveolin-1 on the 17beta-estradiol-mediated inhibition of VSMC proliferation induced by vascular injury. Life Sci 80:800-812 (Pubitemid 46107997)
38. Tan Z, Lin GP, Wang TH (2004) Possible involvement of caveolin-1 in the inhibition of endothelin-1 induced proliferation of vascular smooth muscle cells by 17beta-estradiol. Sheng Li Xue Bao 56:379-383
39. Sheng H, Zhu J, Wu X, Yang D, Zhang J (2007) Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats. Hypertens Res 30:1247-1254 (Pubitemid 351176423)
40. Tutor AS, Penela P, Mayor F Jr (2007) Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells. Cardiovasc Res 76:51-60 (Pubitemid 47362039)